The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Chimerix, Inc(NASDAQ:CMRX) 
Chimerix, Inc., a development-stage biopharmaceutical company, focuses on accelerating the advancement of various medicines that impact in the lives of patients living with cancer and other serious diseases. Its clinical stage development programs include brincidofovir (BCV), an antiviral drug candi...
Website: http://www.chimerix.com
Founded: 2000
Full Time Employees: 43
Sector: Healthcare
Industry: Biotechnology
Chimerix Days Payable Outstanding ttm (DPO)
Chimerix Days Receivable Outstanding ttm (DSO)
Chimerix Days Inventory Outstanding ttm (DIO)
Chimerix Op Cashflow Per Share ttm
Chimerix Free Cashflow Per Share ttm
Chimerix Cash Per Share ttm
Chimerix P/S ratio ttm
Chimerix (GAAP) P/E ratio ttm
Chimerix P/B ratio ttm
No extra charts and metrics for this ticker.